paulhub1/sarms-qsar-predictor
Updated • 7
compound_name stringlengths 3 12 | alias stringlengths 4 20 | compound_class stringclasses 6
values | primary_receptor stringclasses 5
values | secondary_targets stringclasses 10
values | mechanism_of_action stringlengths 17 44 | half_life_hours int64 4 60 | bioavailability stringclasses 3
values | metabolism_pathway stringclasses 2
values | primary_tissue_selectivity stringclasses 8
values | hpt_axis_suppression stringclasses 3
values | potential_hepatotoxicity stringclasses 3
values | lipid_impact stringclasses 7
values | water_retention stringclasses 1
value | aromatization_status stringclasses 2
values | estrogenic_activity stringclasses 3
values | androgenic_activity stringclasses 2
values | solubility stringclasses 3
values | logp float64 2.3 4.5 | purity_percent float64 98.7 99.5 | analytical_methods stringclasses 1
value | status stringclasses 2
values | regulatory_classification stringclasses 3
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ostarine | MK-2866 | SARM | Androgen Receptor | IGF-1 Pathway | Selective androgen receptor modulation | 24 | High | Hepatic via CYP3A4 | Muscle and Bone | Low | Low | Moderate reduction | Low | Non-aromatizing | Minimal | Moderate | Poor aqueous solubility | 3.1 | 99.2 | HPLC MS NMR | Research Only | Unapproved Research Chemical |
RAD-140 | Testolone | SARM | Androgen Receptor | Neuroprotective pathways | High affinity AR agonist | 60 | High | Hepatic | Muscle Dominant | Moderate | Moderate | Negative HDL impact | Low | Non-aromatizing | null | High | Poor aqueous solubility | 4 | 99.1 | HPLC MS NMR | Research Only | Unapproved Research Chemical |
LGD-4033 | Ligandrol | SARM | Androgen Receptor | Osteogenic pathways | Potent AR agonist | 30 | High | Hepatic | Muscle and Bone | Moderate | Low | Negative HDL impact | Low | Non-aromatizing | null | High | Poor aqueous solubility | 3.5 | 99.3 | HPLC MS NMR | Research Only | Unapproved Research Chemical |
YK-11 | YK-11 | SARM/Myostatin Modulator | Androgen Receptor | Myostatin inhibition | Partial AR agonism and myostatin suppression | 10 | Moderate | Hepatic | Muscle | Moderate | Unknown | Unknown | Low | Non-aromatizing | null | Moderate | Poor aqueous solubility | 3.7 | 98.9 | HPLC MS NMR | Research Only | Unapproved Research Chemical |
S-23 | S-23 | SARM | Androgen Receptor | HPG Axis | High potency AR agonist | 12 | High | Hepatic | Muscle Dominant | High | Moderate | Negative HDL impact | Low | Non-aromatizing | null | High | Poor aqueous solubility | 4.2 | 99 | HPLC MS NMR | Research Only | Unapproved Research Chemical |
ACP-105 | ACP-105 | SARM | Androgen Receptor | CNS pathways | Neuroactive AR modulation | 7 | Moderate | Hepatic | Muscle and CNS | Low | Low | Minimal lipid impact | Low | Non-aromatizing | null | Moderate | Poor aqueous solubility | 3 | 98.8 | HPLC MS NMR | Research Only | Unapproved Research Chemical |
S-4 | Andarine | SARM | Androgen Receptor | Prostate tissue | Partial AR agonist | 4 | Moderate | Hepatic | Muscle and Prostate | Moderate | Low | Moderate lipid impact | Low | Non-aromatizing | null | Moderate | Poor aqueous solubility | 3.2 | 99.1 | HPLC MS NMR | Research Only | Unapproved Research Chemical |
GW-501516 | Cardarine | PPARδ Agonist | PPAR-Delta | Metabolic gene regulators | Metabolic transcription activation | 24 | High | Hepatic | Muscle and Fat | null | Moderate | Positive lipid modulation | null | Non-aromatizing | null | null | Poor aqueous solubility | 4.5 | 99.2 | HPLC MS NMR | Research Only | Unapproved Research Chemical |
SR-9009 | Stenabolic | REV-ERB Agonist | REV-ERBα | Clock genes | Circadian rhythm modulation | 4 | Low | Hepatic | Muscle and Liver | null | Low | Positive lipid modulation | null | Non-aromatizing | null | null | Poor aqueous solubility | 3.8 | 98.7 | HPLC MS NMR | Research Only | Unapproved Research Chemical |
MK-677 | Ibutamoren | Ghrelin Mimetic | Growth Hormone Receptor | IGF-1 Axis | GH secretagogue activation | 24 | High | Hepatic | Systemic | null | Low | Neutral | null | Non-aromatizing | null | null | Good aqueous solubility | 2.9 | 99.4 | HPLC MS NMR | Research Only | Unapproved Research Chemical |
Enclomiphene | Enclomiphene Citrate | SERM | Estrogen Receptor | HPG Axis | Estrogen antagonism with LH/FSH elevation | 10 | High | Hepatic | Systemic | null | Low | Neutral | null | Non-aromatizing | Anti-estrogenic | null | Moderate aqueous solubility | 2.5 | 99.5 | HPLC MS NMR | Research Only | Prescription Drug (Off-label Research) |
Clomiphene | Clomid | SERM | Estrogen Receptor | HPG Axis | Mixed estrogen agonist/antagonist | 5 | High | Hepatic | Systemic | null | Moderate | Neutral | null | Partial aromatization | Mixed | null | Good aqueous solubility | 2.3 | 99 | HPLC MS NMR | Prescription | Prescription Drug |
This dataset contains structured pharmacokinetic and receptor-binding information for key androgen and endocrine research compounds including:
Full compound documentation, analytical data, and lab verification available at:
https://maxmusclelabs.com/buy-sarms-uk/
This dataset is provided strictly for:
License: CC-BY 4.0
Keywords: SARMs, androgen receptor, endocrine research, HPG axis, pharmacology